Naltrexone vs Trenbolone
FDA Approved vs Moderate Research
avoid Mechanism-based · 64% Both Naltrexone and Trenbolone carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Molecular Data
Naltrexone Trenbolone
Weight 341.40 Da 270.37 Da (base)
Half-life ~4 hours ~3 days (acetate)
Type Opioid antagonist (C20H23NO4) 19-nortestosterone derivative (C18H22O2), trienone steroid
Key Benefits
Naltrexone
01 Broad anti-inflammatory and immunomodulatory effects via OGF-OGFr axis upregulation
02 Reduction in pro-inflammatory cytokines (TNF-alpha, IL-6, IL-12) through TLR4 antagonism
03 Compensatory upregulation of endogenous endorphins and enkephalins (200-300% increase)
04 Improved immune regulation and rebalancing of Th1/Th2/Th17 responses
05 Reduction in chronic pain through central and peripheral opioid system modulation
06 Potential improvement in mood, anhedonia, and overall well-being via endorphin enhancement
07 Extremely well-tolerated with minimal side effects at low doses
08 Low cost, especially as compounded LDN formulation
Trenbolone
01 Exceptional lean muscle mass accrual with minimal water retention due to non-aromatizing profile
02 Dramatic body recomposition capability -- simultaneous muscle gain and fat loss even in caloric deficit
03 Approximately five times the anabolic and androgenic potency of testosterone (500:500 ratio)
04 Powerful anti-catabolic effects through glucocorticoid receptor antagonism, protecting muscle during dieting
05 Significant increases in strength across all compound movements, often rapid in onset
06 Enhanced nutrient partitioning, directing calories toward lean tissue accretion over fat storage
07 Pronounced muscle hardness, density, and vascularity due to absence of estrogenic water retention
08 Increased IGF-1 production in muscle tissue, amplifying growth signaling pathways
Dosing Protocols
Naltrexone
1.5-4.5 mg/day (LDN) / Once daily at bedtime
Trenbolone
200-400 mg/week / Every other day (acetate) or 2x per week (enanthate)
Recomposition - Moderate (Acetate) 200-300 mg/week (50-75 mg every other day) Every other day
Advanced Cutting (Acetate) 300-400 mg/week (75-100 mg every other day) Every other day
Lean Bulk (Enanthate) 200-400 mg/week 2x per week
Contest Preparation - Advanced 300-500 mg/week Every other day (acetate) or 2x per week (enanthate)
Side Effects
Naltrexone
Vivid dreams or unusually intense dreaming - the most frequently reported side effect, typically diminishes over 1-2 weeks
Initial sleep disruption or insomnia during the first week of treatment
Mild nausea, particularly during the first few days
Transient headache during dose initiation or titration
Trenbolone
Insomnia and severely disrupted sleep architecture (one of the most universally reported side effects, affecting the majority of users)
Night sweats, often drenching, requiring sheet changes
Significantly reduced cardiovascular endurance and aerobic capacity
Increased aggression, irritability, and shortened temper
Anxiety and restlessness, particularly at higher doses
Tren cough: acute, intense coughing fit lasting 30-90 seconds immediately after injection, caused by a small amount of oil entering a blood vessel
Dark-colored urine (oxidized metabolites; not necessarily indicative of kidney damage but should be monitored)
Elevated body temperature and increased sweating throughout the day
Acne and oily skin, particularly on shoulders, back, and chest
Accelerated hair loss in those genetically predisposed to male pattern baldness
Profoundly suppressive of natural testosterone production (near-complete HPT axis shutdown)
Increased heart rate and elevated blood pressure
Contraindications
Current use of opioid medications or active opioid dependence (must be opioid-free 7-10 days minimum)
Acute hepatitis or severe hepatic impairment (primarily relevant at full dose)
Known hypersensitivity to naltrexone
Anticipated need for opioid pain medication (e.g., upcoming surgery - discontinue LDN 3-7 days prior)
First steroid cycle or limited anabolic steroid experience (trenbolone is strictly an advanced-only compound)
Pre-existing cardiovascular disease, cardiomyopathy, or significant cardiac risk factors
History of mental health conditions: anxiety disorders, depression, bipolar disorder, or psychotic episodes
Liver disease or significantly elevated liver enzymes
Kidney disease or impaired renal function
Uncontrolled hypertension
Polycythemia (hematocrit above 54% at baseline)
Prostate cancer or history of hormone-sensitive cancers
Active or recent substance abuse (trenbolone's psychological effects can exacerbate addictive behaviors)
Pregnancy or potential for pregnancy in female partners (extremely virilizing compound)
Research Evidence
Naltrexone Trenbolone
Status FDA Approved Moderate Research
References 5 studies 5 studies
Latest 2023 January 2023
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.